These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 25011399)
1. Individual and environmental contributions to treatment outcomes following a neuroplasticity-principled speech treatment (LSVT LOUD) in children with dysarthria secondary to cerebral palsy: a case study review. Boliek CA; Fox CM Int J Speech Lang Pathol; 2014 Aug; 16(4):372-85. PubMed ID: 25011399 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of intensive voice treatment (LSVT LOUD Boliek CA; Fox CM Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010 [TBL] [Abstract][Full Text] [Related]
3. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria. Fox CM; Boliek CA J Speech Lang Hear Res; 2012 Jun; 55(3):930-45. PubMed ID: 22232407 [TBL] [Abstract][Full Text] [Related]
4. Changes in White Matter Integrity following Intensive Voice Treatment (LSVT LOUD®) in Children with Cerebral Palsy and Motor Speech Disorders. Reed A; Cummine J; Bakhtiari R; Fox CM; Boliek CA Dev Neurosci; 2017; 39(6):460-471. PubMed ID: 28750368 [TBL] [Abstract][Full Text] [Related]
5. Implementing two treatment approaches to childhood dysarthria. Levy ES Int J Speech Lang Pathol; 2014 Aug; 16(4):344-54. PubMed ID: 24673184 [TBL] [Abstract][Full Text] [Related]
6. Intensive treatment of dysarthria secondary to stroke. Mahler LA; Ramig LO Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928 [TBL] [Abstract][Full Text] [Related]
7. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study. Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991 [TBL] [Abstract][Full Text] [Related]
8. Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial. Sackley CM; Rick C; Brady MC; Woolley R; Burton C; Patel S; Masterson-Algar P; Nicoll A; Smith CH; Jowett S; Ives N; Beaton G; Dickson S; Ottridge R; Sharp L; Nankervis H; Clarke CE; BMJ; 2024 Jul; 386():e078341. PubMed ID: 38986549 [TBL] [Abstract][Full Text] [Related]
9. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy. Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088 [TBL] [Abstract][Full Text] [Related]
10. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease. Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176 [TBL] [Abstract][Full Text] [Related]
11. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease. Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195 [TBL] [Abstract][Full Text] [Related]
13. Effects of an intensive voice treatment on articulatory function and speech intelligibility in children with motor speech disorders: A phase one study. Langlois C; Tucker BV; Sawatzky AN; Reed A; Boliek CA J Commun Disord; 2020; 86():106003. PubMed ID: 32505858 [TBL] [Abstract][Full Text] [Related]
14. Intensive dysarthria therapy for younger children with cerebral palsy. Pennington L; Roelant E; Thompson V; Robson S; Steen N; Miller N Dev Med Child Neurol; 2013 May; 55(5):464-71. PubMed ID: 23441834 [TBL] [Abstract][Full Text] [Related]
15. PD Check-In: The development and trial of a supported self-management program for people with Parkinson's disease following intensive speech intervention. Finnimore A; Theodoros D; Rumbach AF Int J Lang Commun Disord; 2022 Jan; 57(1):138-151. PubMed ID: 34767290 [TBL] [Abstract][Full Text] [Related]
16. Speech, communication and use of augmentative communication in young people with cerebral palsy: the SH&PE population study. Cockerill H; Elbourne D; Allen E; Scrutton D; Will E; McNee A; Fairhurst C; Baird G Child Care Health Dev; 2014 Mar; 40(2):149-57. PubMed ID: 23656274 [TBL] [Abstract][Full Text] [Related]
17. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Fox CM; Ramig LO; Ciucci MR; Sapir S; McFarland DH; Farley BG Semin Speech Lang; 2006 Nov; 27(4):283-99. PubMed ID: 17117354 [TBL] [Abstract][Full Text] [Related]
18. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. Sapir S; Spielman JL; Ramig LO; Story BH; Fox C J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595 [TBL] [Abstract][Full Text] [Related]
19. Automatic speech recognition and training for severely dysarthric users of assistive technology: the STARDUST project. Parker M; Cunningham S; Enderby P; Hawley M; Green P Clin Linguist Phon; 2006; 20(2-3):149-56. PubMed ID: 16428231 [TBL] [Abstract][Full Text] [Related]
20. Changes in brain activity following intensive voice treatment in children with cerebral palsy. Bakhtiari R; Cummine J; Reed A; Fox CM; Chouinard B; Cribben I; Boliek CA Hum Brain Mapp; 2017 Sep; 38(9):4413-4429. PubMed ID: 28580693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]